The increased incidence of cancer has been attributed to raised numbers of individuals with obesity/overweight worldwide. Different types of cancers in obese individuals have poor prognosis, high remission rate and resistance to traditional therapies. Literature has identified that lipid metabolism in lipid-laden immune cells, including macrophages, abrogates anti-tumoral responses. In this review we highlight the main metabolic features observed in macrophages in obesity and cancer, and discuss how metabolic changes during metabolic diseases elicits a phenotype in macrophages that could promote malignant progression. This perspective could support new diagnosis and treatment strategies for cancer patients in immunometabolic predisposed condition.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: